Vidara Therapeutics Report issue

For profit Phase 2 Phase 3
Founded: Rosell GA United States (2003)
Status: Acquired by Horizon Pharma (2014) → now Amgen

Organization Overview

First Clinical Trial
2013
NCT01929382
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Vidara Therapeutics Research Ltd | VIDARA THERAPEUTICS RESEARCH LTD